We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.75%
AUM
$224M
AUM Growth
+$13.5M
Cap. Flow
+$5.43M
Cap. Flow %
2.43%
Top 10 Hldgs %
37.65%
Holding
112
New
1
Increased
61
Reduced
31
Closed
1

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$703K
2
CVX icon
Chevron
CVX
+$602K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$453K
4
PFE icon
Pfizer
PFE
+$419K
5
IP icon
International Paper
IP
+$394K

Sector Composition

Rank Sector Weight
1 Industrials 19.7%
2 Healthcare 16.38%
3 Consumer Staples 12.55%
4 Miscellaneous 10.26%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
1
United Parcel Service
UPS
$89.6B
$16.6M 7.43%
154,317
+855
+0.6% +$89K
JNJ icon
2
Johnson & Johnson
JNJ
$641B
$11.2M 5.02%
92,716
-604
-0.6% -$68.6K
XOM icon
3
ExxonMobil
XOM
$641B
$10.5M 4.68%
111,612
+1,074
+1% +$95K
MSFT icon
4
Microsoft
MSFT
$3.82T
$7.69M 3.43%
150,204
+748
+0.5% +$38.9K
GE icon
5
GE Aerospace
GE
$356B
$7.59M 3.39%
50,345
+562
+1% +$82K
PG icon
6
Procter & Gamble
PG
$333B
$6.8M 3.04%
80,299
+878
+1% +$72.1K
IJH icon
7
iShares Core S&P Mid-Cap ETF
IJH
$125B
$6.58M 2.94%
220,170
+3,810
+2% +$112K
IVV icon
8
iShares Core S&P 500 ETF
IVV
$902B
$6.1M 2.72%
28,966
+2,170
+8% +$453K
PFE icon
9
Pfizer
PFE
$159B
$5.81M 2.6%
173,953
+13,115
+8% +$419K
INTC icon
10
Intel
INTC
$477B
$5.36M 2.39%
163,372
+12,330
+8% +$386K
IBM icon
11
IBM
IBM
$224B
$5.28M 2.36%
36,400
+2,433
+7% +$348K
WFC icon
12
Wells Fargo
WFC
$261B
$4.76M 2.13%
100,540
+6,153
+7% +$300K
MRK icon
13
Merck
MRK
$364B
$4.44M 1.98%
80,715
+13,209
+20% +$703K
HON icon
14
Honeywell
HON
$68.4B
$4.31M 1.93%
41,233
-222
-0.5% -$22.8K
CVX icon
15
Chevron
CVX
$394B
$4.23M 1.89%
40,374
+5,982
+17% +$602K
KO icon
16
Coca-Cola
KO
$386B
$4.15M 1.85%
91,559
+226
+0.2% +$10.2K
VVC
17
DELISTED
Vectren Corporation
VVC
$3.9M 1.74%
74,038
+159
+0.2% +$7.95K
ABBV icon
18
AbbVie
ABBV
$454B
$3.87M 1.73%
62,455
+2,585
+4% +$158K
DIS icon
19
Walt Disney
DIS
$186B
$3.86M 1.72%
39,453
-376
-0.9% -$37.6K
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
$3.79M 1.69%
45,542
-950
-2% -$76.7K
SYK icon
21
Stryker
SYK
$126B
$3.3M 1.48%
27,575
-450
-2% -$50.3K
LMT icon
22
Lockheed Martin
LMT
$130B
$3.3M 1.48%
13,306
+400
+3% +$94.3K
WMT icon
23
Walmart Inc
WMT
$819B
$3.24M 1.45%
133,092
+9,117
+7% +$211K
MCD icon
24
McDonald's
MCD
$187B
$3.19M 1.43%
26,522
+454
+2% +$56.9K
DD icon
25
DuPont de Nemours
DD
$18.4B
$3.13M 1.4%
24,892
+2,485
+11% +$327K

Similar funds

Lynch & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Lynch & Associates held 112 positions worth $224M, up 6.4% from $210M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 1.8%. Lynch & Associates opened 1 new position and exited 1, leaving the 112-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Lynch & Associates's largest Q2 2016 buy was State Street Energy Select Sector SPDR ETF: 6,100 shares worth $208K.
  • Lynch & Associates added most to Merck in Q2 2016, an estimated $703K increase.
  • Lynch & Associates's biggest Q2 2016 reduction was Kearny Financial, cutting an estimated $654K.
  • Lynch & Associates fully exited iShares Russell 1000 ETF in Q2 2016, selling an estimated $206K.
  • Lynch & Associates's ten largest holdings make up 38% of its $224M portfolio in Q2 2016.
  • Lynch & Associates opened 1 new position and closed 1 in Q2 2016.
  • Lynch & Associates's portfolio value rose 6.4% quarter-over-quarter to $224M.

Based on Lynch & Associates's 13F filing for Q2 2016, filed 20 Jul 2016.